N. BELDER Et Al. , "INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer," November 29 – December 02, 2023 9 th International BAU Drug Design Congress , 2023
BELDER, N. Et Al. 2023. INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer. November 29 – December 02, 2023 9 th International BAU Drug Design Congress .
BELDER, N., DEMİRKOL CANLI, S., TAMAM, S., ÇULCU, S., SAVAŞ, B., & AKBULUT, H., (2023). INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer . November 29 – December 02, 2023 9 th International BAU Drug Design Congress
BELDER, NEVİN Et Al. "INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer," November 29 – December 02, 2023 9 th International BAU Drug Design Congress, 2023
BELDER, NEVİN Et Al. "INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer." November 29 – December 02, 2023 9 th International BAU Drug Design Congress , 2023
BELDER, N. Et Al. (2023) . "INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer." November 29 – December 02, 2023 9 th International BAU Drug Design Congress .
@conferencepaper{conferencepaper, author={NEVİN BELDER Et Al. }, title={INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer}, congress name={November 29 – December 02, 2023 9 th International BAU Drug Design Congress}, city={}, country={}, year={2023}}